215 related articles for article (PubMed ID: 23321165)
1. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma.
Yuan J; Chen L; Chen X; Sun W; Zhou X
J Int Med Res; 2012; 40(6):2090-7. PubMed ID: 23321165
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
[TBL] [Abstract][Full Text] [Related]
4. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
[TBL] [Abstract][Full Text] [Related]
7. Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma.
Cong C; Wang W; Tian J; Gao T; Zheng W; Zhou C
Cancer Biomark; 2018 Feb; 21(2):449-454. PubMed ID: 29125481
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of microRNA-191 as a potential serum biomarker for diagnosis and prognosis in human osteosarcoma.
Wang T; Ji F; Dai Z; Xie Y; Yuan D
Cancer Biomark; 2015; 15(5):543-50. PubMed ID: 26406942
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
Li Q; Song S; Ni G; Li Y; Wang X
Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
[TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
Wang G; Shen N; Cheng L; Lin J; Li K
Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
[TBL] [Abstract][Full Text] [Related]
12. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-9 as a prognostic biomarker in patients with osteosarcoma.
Fei D; Li Y; Zhao D; Zhao K; Dai L; Gao Z
J Int Med Res; 2014 Aug; 42(4):932-7. PubMed ID: 24962996
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic effect of serum miR-139-5p as an indicator in osteosarcoma.
Zhou L; Ma X; Yue J; Chen T; Wang XY; Wang ZW; Pan J; Lin Y
Cancer Biomark; 2018; 23(4):561-567. PubMed ID: 30347602
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.
Zhang C; Yao C; Li H; Wang G; He X
Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799
[TBL] [Abstract][Full Text] [Related]
16. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
17. Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Diao ZB; Sun TX; Zong Y; Lin BC; Xia YS
J Int Med Res; 2020 Dec; 48(12):300060520967818. PubMed ID: 33284712
[TBL] [Abstract][Full Text] [Related]
18. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
[TBL] [Abstract][Full Text] [Related]
19. The expression significance of serum MiR-21 in patients with osteosarcoma and its relationship with chemosensitivity.
Hua Y; Jin Z; Zhou F; Zhang YQ; Zhuang Y
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):2989-2994. PubMed ID: 28742209
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
Xu SH; Yang YL; Han SM; Wu ZH
World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]